Cardiovascutar risk factors and homocysteine in epitepsy

被引:39
作者
Elliotta, John O.
Jacobson, Mercedes P.
Haneef, Zulfi
机构
[1] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA
[2] Temple Univ, Sch Med, Dept Neurol, Philadelphia, PA 19140 USA
关键词
epilepsy; cardiovascular risk; factors; framingham risk; score; homocysteine;
D O I
10.1016/j.eplepsyres.2007.07.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Epidemiological studies have found the risk for heart disease and stroke are increased in persons with epilepsy. Anti-epileptic drugs (AEDs) have varying effects on serum Lipids and homocysteine-an independent risk factor for coronary disease. The prevalence of cardiovascular risk factors (high cholesterol, hypertension, diabetes, obesity and smoking) and homocysteine were investigated in a multiethnic epilepsy population. Data included demographics, clinical factors, tab assessments and supplementation patterns. Mean age was 45 years (71 males and 94 females)-75 were African American, 27 Latina and 60 Caucasian. Fifty-two percent of participants had two or more cardiovascular risk factors when compared with rates for the general population of 28%. The Framingham risk score (FRS) assessment was also used to compare risk levels. Twenty-nine percent of men and 1% of women had a FRS indicating >5% level of risk, only 7% had a FRS > 10%. Cardiovascular screening and primary preventative recommendations based on the American Heart Association and supplementation should be suggested for the adult epilepsy population when appropriate. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:113 / 123
页数:11
相关论文
共 68 条
[11]   Trends in serum lipids and lipoproteins of adults, 1960-2002 [J].
Carroll, MD ;
Lacher, DA ;
Sorlie, PD ;
Cleeman, JI ;
Gordon, DJ ;
Wolz, M ;
Grundy, SM ;
Johnson, CL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (14) :1773-1781
[12]  
*CDCP, 2003, MMWR-MORBID MORTAL W, V52, P764
[13]  
Celentano Aldo, 2005, Ital Heart J, V6, P557
[14]   Preventing cardiovascular disease in the 21st century: Therapeutic and preventive implications of current evidence [J].
Daviglus M.L. ;
Lloyd-Jones D.M. ;
Pirzada A. .
American Journal of Cardiovascular Drugs, 2006, 6 (2) :87-101
[15]  
Deda G, 2003, J PEDIATR ENDOCR MET, V16, P193
[16]   Carbamazepine and valproic acid: Effects on the serum lipids and liver functions in children [J].
Demircioglu, S ;
Soylu, A ;
Dirik, E .
PEDIATRIC NEUROLOGY, 2000, 23 (02) :142-146
[17]   The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy [J].
Eirís, J ;
Novo-Rodríguez, MI ;
Del Río, M ;
Meseguer, P ;
Del Río, MC ;
Castro-Gago, M .
EPILEPSY RESEARCH, 2000, 41 (01) :1-7
[18]   The burden of adult hypertension in the United States 1999 to 2000 - A rising tide [J].
Fields, LE ;
Burt, VL ;
Cutler, JA ;
Hughes, J ;
Roccella, EJ ;
Sorlie, P .
HYPERTENSION, 2004, 44 (04) :398-404
[19]   Fasting vs nonfasting plasma homocysteine concentrations for diagnosis of hyperhomocysteinemia [J].
Fokkema, MR ;
Gilissen, MF ;
van Doormaal, JJ ;
Volmer, M ;
Kema, IP ;
Muskiet, FAJ .
CLINICAL CHEMISTRY, 2003, 49 (05) :818-821
[20]   The epidemiology of the comorbidity of epilepsy in the general population [J].
Gaitatzis, A ;
Carroll, K ;
Majeed, A ;
Sander, JW .
EPILEPSIA, 2004, 45 (12) :1613-1622